Europe’s digital health market is expanding rapidly and presents significant opportunities for North American healthcare and technology companies.
The market is expected to grow at a compound annual growth rate (CAGR) of around 16% through 2030, driven by rising chronic disease prevalence, ageing populations, improved digital infrastructure, and the accelerated adoption of digital health solutions following COVID‑19.
These developments are reshaping how healthcare is delivered across Europe, improving access, enabling remote care, and placing greater emphasis on patient‑centred solutions.
What is driving growth in Europe’s digital health market?
Europe’s digital health growth is driven by several structural factors, including:
- Increasing incidence of chronic and long‑term conditions
- Rapid digitalisation of healthcare systems
- High internet and smartphone penetration
- Growing demand for remote and home‑based care
- Public and private investment in healthcare innovation
Ageing populations across the EU are increasing pressure on healthcare systems, accelerating the adoption of digital tools that improve efficiency and access to care.
How large is the digital health market in Europe?
Based on recent market analyses, Europe’s digital health market is now valued at over USD 80–100 billion, with strong double‑digit growth expected through the early 2030s. Recent forecasts consistently point to annual growth rates between 17% and 22%, driven by the continued digitalisation of healthcare systems and rising demand for remote and data‑enabled care.
Market expansion is supported by increasing healthcare demand across ageing populations, government‑backed digital health initiatives, and the sustained adoption of telehealth and remote monitoring solutions following COVID‑19.
For international companies, Europe represents a large but highly fragmented opportunity, requiring local market knowledge and country‑specific execution.
Which European countries lead digital health adoption?
United Kingdom
The UK is one of Europe’s fastest‑growing digital health markets. It is characterised by their strong investment in health technology, leadership in remote monitoring and wearables, and a well established innovation ecosystem centred around London, Oxford and Cambridge. The UK’s academic institutions and research networks continue to support digital health innovation.
France
France is a major digital health investor, particularly in diagnostics and screening software, radiology analytics, as well as AI‑driven diagnostic tools for chronic diseases. Government support and healthcare system modernisation continue to fuel growth.
Germany
Germany is Europe’s largest healthcare market but has historically lagged in digital adoption. This is changing following the introduction of the Digital Healthcare Act, which expanded access to both digital and in‑person healthcare services and opened the market to digital health solutions.
Why is mobile health (mHealth) the largest segment?
Mobile health represents the largest share of Europe’s digital health market.
Growth is driven by:
- Widespread smartphone adoption
- Increasing use of health and monitoring apps
- Demand for remote patient monitoring
Digital tools now support both younger and older populations, making mobile platforms a cornerstone of European digital health adoption.
Who are the key players in Europe’s digital health market?
The European digital health landscape includes a mix of established players and fast‑growing startups. Innovation is driven by:
- Product development focused on remote care
- AI‑enabled diagnostics
- Wearable health technologies
- Strategic partnerships and acquisitions
Examples:
- Oura Ring (Finland): A wearable device that tracks sleep, activity, and health metrics using sensor technology
- Mendelian (UK): An AI‑based diagnostics platform focused on early detection of rare diseases, supporting clinicians and easing pressure on healthcare systems
Key takeaways
- Europe offers strong opportunities for digital health growth but remains highly fragmented
- Market entry requires local knowledge of healthcare systems, regulations, and reimbursement
- A one‑size‑fits‑all European strategy rarely works
- Local commercial support often accelerates adoption and reduces execution risk
- Partnering with Europe‑based experts helps North American companies scale more effectively
Written by Harinya Yadav, VP MedTech & Life Sciences at EuroDev.
Related articles
-
MDR vs. FDA 510(k): Where U.S. Playbooks Break in Europe (and How to Fix Them)
Last updated: 2 March 2026Learn the key differences between FDA 510(k) and EU MDR, including classification changes, clinical...
Read more -
Expanding Non-Invasive Monitoring Tech into Europe: A Path for North American Innovators
Last updated: 26 August 2025Europe’s healthcare systems need scalable, non-invasive monitoring tools. Discover key...
Read more -
Navigating the European Market: Challenges and Opportunities for American Medical Companies
Last updated: 23 July 2025Europe’s medical device market offers huge growth potential for American MedTech companies, but...
Read more